These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

319 related articles for article (PubMed ID: 34186110)

  • 1. Investigation of α-Synuclein Species in Plasma Exosomes and the Oligomeric and Phosphorylated α-Synuclein as Potential Peripheral Biomarker of Parkinson's Disease.
    Zheng H; Xie Z; Zhang X; Mao J; Wang M; Wei S; Fu Y; Zheng H; He Y; Chen H; Xu Y
    Neuroscience; 2021 Aug; 469():79-90. PubMed ID: 34186110
    [TBL] [Abstract][Full Text] [Related]  

  • 2. α-Synuclein in salivary extracellular vesicles as a potential biomarker of Parkinson's disease.
    Cao Z; Wu Y; Liu G; Jiang Y; Wang X; Wang Z; Feng T
    Neurosci Lett; 2019 Mar; 696():114-120. PubMed ID: 30579996
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A longitudinal study on α-synuclein in plasma neuronal exosomes as a biomarker for Parkinson's disease development and progression.
    Niu M; Li Y; Li G; Zhou L; Luo N; Yao M; Kang W; Liu J
    Eur J Neurol; 2020 Jun; 27(6):967-974. PubMed ID: 32150777
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phosphorylated α-synuclein in diluted human serum as a biomarker for Parkinson's disease.
    Chen WR; Chen JC; Chang SY; Chao CT; Wu YR; Chen CM; Chou C
    Biomed J; 2022 Dec; 45(6):914-922. PubMed ID: 34974168
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oral Mucosa Derived α-Synuclein as a Potential Diagnostic Biomarker for Parkinson's Disease.
    Zheng Y; Yu Z; Zhao J; Cai H; Wang Z; Wang X; Feng T
    Front Aging Neurosci; 2022; 14():867528. PubMed ID: 35418851
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long Noncoding RNA POU3F3 and α-Synuclein in Plasma L1CAM Exosomes Combined with β-Glucocerebrosidase Activity: Potential Predictors of Parkinson's Disease.
    Zou J; Guo Y; Wei L; Yu F; Yu B; Xu A
    Neurotherapeutics; 2020 Jul; 17(3):1104-1119. PubMed ID: 32236821
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Central Nervous System-Derived Exosomal Alpha-Synuclein in Serum May Be a Biomarker in Parkinson's Disease.
    Si X; Tian J; Chen Y; Yan Y; Pu J; Zhang B
    Neuroscience; 2019 Aug; 413():308-316. PubMed ID: 31102760
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Erythrocytic α-Synuclein as a potential biomarker for Parkinson's disease.
    Tian C; Liu G; Gao L; Soltys D; Pan C; Stewart T; Shi M; Xie Z; Liu N; Feng T; Zhang J
    Transl Neurodegener; 2019; 8():15. PubMed ID: 31123587
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of α-synuclein oligomers in red blood cells as a potential biomarker of Parkinson's disease.
    Wang X; Yu S; Li F; Feng T
    Neurosci Lett; 2015 Jul; 599():115-9. PubMed ID: 25998655
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Microglia as modulators of exosomal alpha-synuclein transmission.
    Xia Y; Zhang G; Han C; Ma K; Guo X; Wan F; Kou L; Yin S; Liu L; Huang J; Xiong N; Wang T
    Cell Death Dis; 2019 Feb; 10(3):174. PubMed ID: 30787269
    [TBL] [Abstract][Full Text] [Related]  

  • 11. α-Synuclein in blood exosomes immunoprecipitated using neuronal and oligodendroglial markers distinguishes Parkinson's disease from multiple system atrophy.
    Dutta S; Hornung S; Kruayatidee A; Maina KN; Del Rosario I; Paul KC; Wong DY; Duarte Folle A; Markovic D; Palma JA; Serrano GE; Adler CH; Perlman SL; Poon WW; Kang UJ; Alcalay RN; Sklerov M; Gylys KH; Kaufmann H; Fogel BL; Bronstein JM; Ritz B; Bitan G
    Acta Neuropathol; 2021 Sep; 142(3):495-511. PubMed ID: 33991233
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phosphorylated α-synuclein can be detected in blood plasma and is potentially a useful biomarker for Parkinson's disease.
    Foulds PG; Mitchell JD; Parker A; Turner R; Green G; Diggle P; Hasegawa M; Taylor M; Mann D; Allsop D
    FASEB J; 2011 Dec; 25(12):4127-37. PubMed ID: 21865317
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Different patterns of exosomal α-synuclein between Parkinson's disease and probable rapid eye movement sleep behavior disorder.
    Yan YQ; Pu JL; Zheng R; Fang Y; Gu LY; Guo T; Si XL; Zhou C; Chen Y; Liu Y; Guan XJ; Xu XJ; Yan YP; Yin XZ; Zhang MM; Tao ZH; Zhang BR
    Eur J Neurol; 2022 Dec; 29(12):3590-3599. PubMed ID: 36047985
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma and serum alpha-synuclein as a biomarker in Parkinson's disease: A meta-analysis.
    Zubelzu M; Morera-Herreras T; Irastorza G; Gómez-Esteban JC; Murueta-Goyena A
    Parkinsonism Relat Disord; 2022 Jun; 99():107-115. PubMed ID: 35717321
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Salivary alpha-synuclein as a biomarker for Parkinson's disease: a systematic review.
    Bougea A; Koros C; Stefanis L
    J Neural Transm (Vienna); 2019 Nov; 126(11):1373-1382. PubMed ID: 31401695
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exosome-mediated delivery of antisense oligonucleotides targeting α-synuclein ameliorates the pathology in a mouse model of Parkinson's disease.
    Yang J; Luo S; Zhang J; Yu T; Fu Z; Zheng Y; Xu X; Liu C; Fan M; Zhang Z
    Neurobiol Dis; 2021 Jan; 148():105218. PubMed ID: 33296726
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oligomeric α-Syn and SNARE complex proteins in peripheral extracellular vesicles of neural origin are biomarkers for Parkinson's disease.
    Agliardi C; Meloni M; Guerini FR; Zanzottera M; Bolognesi E; Baglio F; Clerici M
    Neurobiol Dis; 2021 Jan; 148():105185. PubMed ID: 33217562
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Exosomal/Total α-Synuclein Ratio in Plasma Is Associated With Glucocerebrosidase Activity and Correlates With Measures of Disease Severity in PD Patients.
    Cerri S; Ghezzi C; Sampieri M; Siani F; Avenali M; Dornini G; Zangaglia R; Minafra B; Blandini F
    Front Cell Neurosci; 2018; 12():125. PubMed ID: 29867358
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection and Assessment of α-Synuclein Oligomers in the Urine of Parkinson's Disease Patients.
    Nam D; Lee JY; Lee M; Kim J; Seol W; Son I; Ho DH
    J Parkinsons Dis; 2020; 10(3):981-991. PubMed ID: 32444560
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oligomeric and phosphorylated alpha-synuclein as potential CSF biomarkers for Parkinson's disease.
    Majbour NK; Vaikath NN; van Dijk KD; Ardah MT; Varghese S; Vesterager LB; Montezinho LP; Poole S; Safieh-Garabedian B; Tokuda T; Teunissen CE; Berendse HW; van de Berg WD; El-Agnaf OM
    Mol Neurodegener; 2016 Jan; 11():7. PubMed ID: 26782965
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.